Aspirin reduces risk of colon cancer
Results of a new study show that low dose aspirin can reduce risk of colon cancer.
Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute.